Alpha 2.0
Login Register
» Authors » Daniela Thorwarth

Daniela Thorwarth

Explore the profile of Daniela Thorwarth including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 121
Citations 3043
Followers 0
Related Specialties
Oncology
Radiology
Biophysics
Top 10 Co-Authors
Daniel Zips
David Monnich
Cihan Gani
Simon Boeke
Marcel Nachbar
Konstantin Nikolaou
Markus Alber
Frank Paulsen
Stefan Welz
Sara Leibfarth
Published In
Radiother Oncol
Phys Imaging Radiat Oncol
Phys Med Biol
Acta Oncol
Strahlenther Onkol
Affiliations
Soon will be listed here.
Recent Articles
11.
Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)
Bodensohn R, Fleischmann D, Maier S, Anagnostatou V, Garny S, Nitschmann A, et al.
Clin Transl Radiat Oncol . 2023 Dec; 45:100706. PMID: 38116137
Background And Purpose: The PRIDE trial (NOA-28; ARO-2022-12; NCT05871021) is scheduled to start recruitment in October 2023. Its primary objective is to enhance median overall survival (OS), compared to historical...
12.
MRI-Guided Adaptive Radiation Therapy
Benitez C, Chuong M, Kunzel L, Thorwarth D
Semin Radiat Oncol . 2023 Dec; 34(1):84-91. PMID: 38105097
Magnetic resonance imaging-guided radiation therapy (MRIgRT) has improved soft tissue contrast over computed tomography (CT) based image-guided RT. Superior visualization of the target and surrounding radiosensitive structures has the potential...
13.
Reproducibility of diffusion-weighted magnetic resonance imaging in head and neck cancer assessed on a 1.5 T MR-Linac and comparison to parallel measurements on a 3 T diagnostic scanner
Habrich J, Boeke S, Fritz V, Koerner E, Nikolaou K, Schick F, et al.
Radiother Oncol . 2023 Dec; 191:110046. PMID: 38070687
Background And Purpose: Before quantitative imaging biomarkers (QIBs) acquired with magnetic resonance imaging (MRI) can be used for interventional trials in radiotherapy (RT), technical validation of these QIBs is necessary....
14.
Impact of MRI on target volume definition in head and neck cancer patients
Clasen K, Nachbar M, Gatidis S, Zips D, Thorwarth D, Welz S
Radiat Oncol . 2023 Sep; 18(1):148. PMID: 37674171
Background: Target volume definition for curative radiochemotherapy in head and neck cancer is crucial since the predominant recurrence pattern is local. Additional diagnostic imaging like MRI is increasingly used, yet...
15.
Longitudinal monitoring of Apparent Diffusion Coefficient (ADC) in patients with prostate cancer undergoing MR-guided radiotherapy on an MR-Linac at 1.5 T: a prospective feasibility study
Almansour H, Schick F, Nachbar M, Afat S, Fritz V, Thorwarth D, et al.
Radiol Oncol . 2023 Jun; 57(2):184-190. PMID: 37341194
Background: Hybrid MRI linear accelerators (MR-Linac) might enable individualized online adaptation of radiotherapy using quantitative MRI sequences as diffusion-weighted imaging (DWI). The purpose of this study was to investigate the...
16.
Correction : Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced non-small cell lung cancer: the PUMA trial
Regnery S, de Colle C, Eze C, Corradini S, Thieke C, Sedlaczek O, et al.
Radiat Oncol . 2023 Jun; 18(1):99. PMID: 37291628
No abstract available.
17.
Automatic AI-based contouring of prostate MRI for online adaptive radiotherapy
Nachbar M, Lo Russo M, Gani C, Boeke S, Wegener D, Paulsen F, et al.
Z Med Phys . 2023 Jun; 34(2):197-207. PMID: 37263911
Background And Purpose: MR-guided radiotherapy (MRgRT) online plan adaptation accounts for tumor volume changes, interfraction motion and thus allows daily sparing of relevant organs at risk. Due to the high...
18.
Prospective evaluation of in vivo and phantom repeatability and reproducibility of diffusion-weighted MRI sequences on 1.5 T MRI-linear accelerator (MR-Linac) and MR simulator devices for head and neck cancers
McDonald B, Salzillo T, Mulder S, Ahmed S, Dresner A, Preston K, et al.
Radiother Oncol . 2023 May; 185:109717. PMID: 37211282
Introduction: Diffusion-weighted imaging (DWI) on MRI-linear accelerator (MR-linac) systems can potentially be used for monitoring treatment response and adaptive radiotherapy in head and neck cancers (HNC) but requires extensive validation....
19.
Machine learning identifies multi-parametric functional PET/MR imaging cluster to predict radiation resistance in preclinical head and neck cancer models
Boeke S, Winter R, Leibfarth S, Krueger M, Bowden G, Cotton J, et al.
Eur J Nucl Med Mol Imaging . 2023 May; 50(10):3084-3096. PMID: 37148296
Purpose: Tumor hypoxia and other microenvironmental factors are key determinants of treatment resistance. Hypoxia positron emission tomography (PET) and functional magnetic resonance imaging (MRI) are established prognostic imaging modalities to...
20.
Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced: the PUMA trial
Regnery S, de Colle C, Eze C, Corradini S, Thieke C, Sedlaczek O, et al.
Radiat Oncol . 2023 May; 18(1):74. PMID: 37143154
Background: Patients with locally-advanced non-small-cell lung cancer (LA-NSCLC) are often ineligible for surgery, so that definitive chemoradiotherapy (CRT) represents the treatment of choice. Nevertheless, long-term tumor control is often not...